NCT00841958View on ClinicalTrials.gov

Endocardial Stem Cells Approach Efficacy

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Myocardial Ischemia
Interventions
PROCEDURE

Autologous bone marrow mononuclear stem cells or peripheral blood stem cells

Cells concentration is 150х106 cells/ml (2ml) with CD34+ cells=2.5±1.44%

Trial Locations (1)

630055

State Research Institute of Circulation Pathology, Novosibirsk

All Listed Sponsors
lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT00841958 - Endocardial Stem Cells Approach Efficacy | Biotech Hunter | Biotech Hunter